Editas Medicine, Inc. balance sheet

At the end of fiscal 2025, Editas Medicine, Inc. had total assets of $187m, total liabilities of $159m and shareholders' equity of $27.3m. It held $147m in cash against $58.6m of debt: net cash of $88.0m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Editas Medicine, Inc.: balance sheet, annual
Fiscal year	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	185	147	135	238	140	204	142	124	132	147	182
Receivables	0	1	0	0	6	0	5	10	16	15	3
Total current assets	187	332	375	464	419	507	357	341	289	164	218
Total assets	229	373	420	509	573	677	514	499	342	187	237
Accounts payable	5	4	5	6	6	5	10	8	5	3	5
Deferred revenue (current)	0	13	16	24	21	11	8	8	6	0	32
Total current liabilities	33	37	36	60	58	47	60	63	77	46	68
Short-term debt	—	—	—	—	—	—	—	0	5	5	8
Long-term debt	—	—	—	—	—	—	—	0	52	54	48
Total debt	0	0	0	0	0	0	0	0	57	59	56
Total liabilities	95	165	184	246	179	124	154	150	207	159	132
Shareholders' equity	135	208	236	262	394	554	361	349	134	27	105
Net debt (negative = net cash)	−185	−147	−135	−238	−140	−204	−142	−124	−74	−88	−126
Shares outstanding	36m	45m	49m	54m	63m	68m	69m	82m	83m	98m	98m

US$ millions unless shown otherwise. Fiscal quarters.

Editas Medicine, Inc.: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	0	16	1	1	8	15	3	3
Total current assets	271	289	225	183	177	164	128	218
Total assets	328	342	264	211	202	187	149	237
Accounts payable	12	5	5	7	3	3	4	5
Deferred revenue (current)	15	6	2	0	0	0	—	32
Total current liabilities	72	77	73	66	62	46	40	68
Short-term debt	—	5	5	5	5	5	8	8
Long-term debt	—	52	50	52	54	54	47	48
Total debt	—	57	55	57	59	59	55	56
Total liabilities	152	207	201	191	188	159	145	132
Shareholders' equity	176	134	62	19	13	27	4	105
Shares outstanding	83m	83m	84m	87m	93m	98m	98m	98m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: EDIT vs SPRO EDIT vs STRO EDIT vs OCUL

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Editas Medicine, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Editas Medicine, Inc.